国际妇产科联盟2023年子宫内膜癌分期系统对放射肿瘤患者更优
该文评述国际妇产科联盟(FIGO)2023年子宫内膜癌分期系统相较2009年系统的显著变化,新系统首次纳入淋巴血管间隙浸润、组织学及分子分型,使早期疾病分期发生改变(IAmPOLEmut与IICmp53abn)。作者认为FIGO 2023为放射肿瘤科医生提供个体化治疗建议更有用,并有助于辅助治疗决策。
要点
- FIGO 2023首次纳入非解剖因素(淋巴血管间隙浸润、组织学)与分子分型,影响早期疾病分期。
- 新分期设独立亚分期,改善辅助治疗决策。
- 作者认为FIGO 2023对放射肿瘤科医生制定个体化治疗建议更有用。
核心结论
- 作者认为FIGO 2023对旨在提供个体化治疗建议的放射肿瘤科医生更有用。
- FIGO 2023要求将分期系统的认知从传统解剖边界为基础转变为整合解剖与肿瘤生物学作为关键预后因素并兼顾治疗决策信息。
研究设计与样本
- 本文为评述性文章,比较FIGO 2023与2009年子宫内膜癌分期系统的变化及其对放射肿瘤学实践的意义。
主要发现
- FIGO 2023较14年前制定的2009年系统有显著变化,首次纳入非解剖因素(淋巴血管间隙浸润和组织学)及分子分型。
- 分子分型影响早期疾病分期,具体为IAmPOLEmut与IICmp53abn。
- 上述变化旨在为患者提供高准确度的预后预测并识别与治疗相关的不同亚组。
- FIGO 2023整合解剖、组织病理学和分子特征,并设独立亚分期以改善辅助治疗决策。
- 作者指出新分期系统的实用性虽有争议,但仍认为其对放射肿瘤科医生更有用。
临床怎么用
- 作者认为FIGO 2023对旨在提供个体化治疗建议的放射肿瘤科医生更有用。
- FIGO 2023设独立亚分期,改善辅助治疗决策。
局限性
- 原文提到新分期系统的实用性存在争议。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The International Federation of Gynecology and Obstetrics (FIGO) 2023 staging system for endometrial cancer has marked changes from the previous staging system instituted 14 years prior in 2009. The new staging system includes nonanatomic factors for the first time (lymphovascular space invasion and histology) and molecular classification, which impacts the stage in early-stage disease (IAmPOLEmut and IICmp53abn). The purpose of these changes was to provide (1) high accuracy in the predictive prognosis for patients and (2) identification of distinct treatment-relevant subgroups. Our understanding of the biology and natural history of endometrial cancer has undergone a radical transformation since the Cancer Genome Atlas results in 2013. The 2023 FIGO staging system harmonizes and integrates old and new knowledge on anatomic, histopathologic, and molecular features. Moreover, FIGO 2023 has distinct substages that improve adjuvant treatment decision making. Although the practicality of the new staging system has been debated, we postulate that FIGO 2023 is more useful for radiation oncologists aiming to provide personalized care recommendations. FIGO 2023 requires a change in our perception of a staging system, from a traditional anatomic borders-based system to a staging system integrating anatomy and tumor biology as pivotal prognostic factors for patients while providing important information for treatment decision making.
引用
- Gaffney D, Suneja G, Weil C, et al. International Federation of Gynecology and Obstetrics Endometrial 2023 Is Better For Radiation Oncology Patients. Pract Radiat Oncol. 2024. PMID: 39019210. doi:10.1016/j.prro.2024.05.010
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。